Journal
MULTIPLE SCLEROSIS
Volume 9, Issue 5, Pages 472-475Publisher
ARNOLD, HODDER HEADLINE PLC
DOI: 10.1191/1352458503ms954oa
Keywords
cerebrospinal fluid; protein purification; multiple sclerosis
Categories
Funding
- NINDS NIH HHS [NS 41549, NS 32623, NS 07321] Funding Source: Medline
- NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007321, P01NS032623, R01NS041549] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Proteomics combines two-dimensional gel electrophoresis and peptide mass fingerprinting and can potentially identify a protein(s) unique to disease. Such proteins can be used either for diagnosis or may be relevant to the pathogenesis of disease. Because patients with multiple sclerosis ( MS) have increased amounts of immunoglobulin (Ig) G in their cerebro spinal fluid ( C SF) that is directed against an as yet unidentified protein, we are applying proteomics to MS CSF, studies that require optimal separation of proteins in human C SF. We found that recovery of proteins from C SF of MS patients was improved using ultrafiltration, rather than dialysis, for desalting. Resolution of these proteins was enhanced by acetone precipitation of desalted C SF before electrophoresis and by fractionation of CSF using C ibacron Blue sepharose affinity chromatography. Improved protein recovery and resolution will facilitate excision from gels for analysis by peptide mass fingerprinting.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available